Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2024-10-29
2025-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does the cream lower the appearance of forehead wrinkles, crow's feet, under-eye wrinkles, and nasolabial folds when participants smile or raise their eyebrows?
* Does the cream help reduce horizontal neck folds when participants lower their heads?
About 45 healthy women between the ages of 18 and 35 will take part in this 10-week study. They will:
* Stop using other anti-aging products for 2 weeks (wash-out period)
* Apply the study cream on their face and neck twice a day for 8 weeks
* Visit the clinic 4 times for facial and neck photo collection and clinical assessments
* Learn to make standard facial expressions for photo comparisons
Researchers will compare wrinkle changes using dermatologist scores and photo grading at different time points.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cream Short-term Efficacy Clinical Study
NCT07067086
Eye Cream 8-Week Efficacy Clinical Study
NCT07079501
Test Serum Clinical Study
NCT07200635
Evaluation of the Anti-aging Efficacy of Four Skin Health Products
NCT05473832
In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365
NCT07208227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Investigational Cream Arm
Participants apply the investigational cream (Formula# 899675 44A) on the entire face and neck twice daily for 8 weeks following a 2-week wash-out period. Application is supervised on-site at baseline and self-administered at home thereafter. Clinical assessments and facial/neck image capture are conducted at baseline, week 4, and week 8.
Anti-Dynamic Line Cream
Topical cream (Formula# 899675 44A) applied to the full face and neck twice daily for 8 weeks. Participants apply 1 g each time in the morning and evening after cleansing, with massage on wrinkle-prone areas. Used after a 2-week wash-out period with standard skincare.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anti-Dynamic Line Cream
Topical cream (Formula# 899675 44A) applied to the full face and neck twice daily for 8 weeks. Participants apply 1 g each time in the morning and evening after cleansing, with massage on wrinkle-prone areas. Used after a 2-week wash-out period with standard skincare.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. All skin types will be contained, including 50% sensitive skin.
3. Regular users of cleanser, anti-aging cream and sunscreen product.
4. Self-claim having concerns of wrinkles problems.
5. Presenting with obvious dynamic wrinkles while making smiling/raising eyebrow expression ( expression reach max condition) evaluated by Dermatologist:
* Raise eyebrow: Forehead wrinkles (Loreal Atlas, 1\<grade≤4)
* Smile: Underneath eye wrinkles (Loreal Atlas, grade≥3)
* Smile: Crow's feet wrinkles (Loreal Atlas, grade≥3)
* Smile: Nasolabial folds (Loreal Atlas, grade\>1)
6. Did not participate in any clinical test or cosmetic product test on skin within 3 months.
7. Did not participate any chemical procedures for previous 2 months; and willing to not participate any procedures during the whole study.
8. No disagreement of dermatologist because of other reasons that exclude the participation of the Subject.
9. In general, good health at the time of the study.
10. Willing and able to participate as evidenced by signing of informed consent and photorelease form.
11. Must be willing to comply with all study protocol requirements (pay attention to not take topical or oral treatment like retinol, hormone, antioxidant health-care products which may affect the efficacy of test products).
Exclusion Criteria
2. Subject deprived of rights by a court or administrative order.
3. Major subject to a guardianship order.
4. Subject residing in a health or social care establishment.
5. Patient in an emergency setting.
6. Subject with a skin disease in the test areas (particularly e.g., acne, rosacea, eczema).
7. Subject presenting a stable or progressive serious disease (per investigator's assessment).
8. Immuno-compromised subject.
9. Subject with history of allergy to cosmetic or personal care products or ingredients.
10. Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment).
11. Subjects regularly practicing aquatic or nautical sports.
12. Subjects regularly attending a sauna.
13. Subject with cardiovascular or circulatory history.
14. Subject with a history of skin cancer or malignant melanoma.
15. Intake of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatories or immune-suppressants in the last 6 months before study
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ChinaNorm
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C24005075
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.